{"id":2217,"date":"2015-08-10T00:00:00","date_gmt":"2015-08-10T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.comindex.php\/2015\/08\/10\/pinup-081015\/"},"modified":"2019-02-06T02:14:30","modified_gmt":"2019-02-06T02:14:30","slug":"pinup-081015","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup-081015\/","title":{"rendered":"Pharma Backchannel Chats, FDA’s “Obscene” Drug Safety Program, DTC Pays Off!"},"content":{"rendered":"

Pharma Industry News Update<\/b>: 10 August 2015<\/p>\n\n

Safeguarding Medical Conference Twitter Hashtags<\/b> A Survey <\/p>\n

A study by Desai et al<\/i> examines the use of Twitter by commercial entities and concludes that due to the reach of their Twitter accounts these entities exert an equal or greater amount of influence than healthcare providers via social media.\u00a0<\/p>\n

\u00a0<\/p>\n

The fear is that “third parties can use this influence to promote their products or services instead of sharing unbiased, evidence-based information,” say the authors. They argue that whereas conference organizers mitigate “detailing” at live events — e.g., not allowing third parties to select speakers at plenary and other sessions, not allowing third parties to pass out literature in-and-around classrooms, and restricting learner access to third parties to one geographic location (“exhibition hall”) and only during specific periods of time that do not conflict with other scientific sessions — there are no such restrictions in the virtual realm. <\/p>\n

Consequently, the authors propose safeguards to limit third party — i.e., pharmaceutical — “detailing” via Twitter “backchannels” as they call it. What are these proposed safeguards? Are they necessary? <\/p>\n

<\/p>\n

Take the Survey Here<\/a>.<\/p>\n

<\/p>\n\n

\"VirtualThe Emerging Virtual Medical Conference<\/b> Opportunities for Pharma, HCPs and Patients
“The medical conference is dead, long live the medical conference,” is the title of a SlideShare presentation by Len Starnes (@lenstarnes), a respected digital health-care consultant and former e-business leader for Bayer Schering Pharma’s Primary Care business unit. Starnes is referring to the emergence of the “virtual” medical conference, which he believes will soon be adopted in one form or another by all medical societies. Starnes predicts that virtual attendees of medical conferences will soon outnumber physical attendees. <\/p>\n

This article describes the changes occurring viz-a-viz major medical conferences and the impact this will have on the pharmaceutical industry, medical societies, healthcare professionals, and patients. <\/p>\n

Topics include (partial list)<\/b>: <\/p>\n